Application Number 5025502 (Class 5)
Application Number:5025502
Status: Unknown
Class:5
Applicant:CELGENE CORPORATION
Filing Date:Wed, 30 Jun 2021
In Progress
Is this your trademark application?
"application #5025502" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5025502 |
| Nature/Scope of business | Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system. |
| Publication | In Journal No. 2009 |
| Status | Unknown |
| Applicant: | CELGENE CORPORATION |
| Applicant Address | 86 Morris Avenue Summit, New Jersey, 07901, U.S.A. A Delaware, U.S.A. corporation |
| Jurisdiction | DELHI |
| Agent | RAHUL CHAUDHRY & PARTNERS |
| Agent Address | RCY HOUSE, C-235, DEFENCE COLONY, NEW DELHI-110024 |
Frequently Asked Questions
Who is the owner of trademark application number 5025502? ▾
The trademark application number 5025502 is owned by CELGENE CORPORATION.
Which class does trademark application number 5025502 belong to? ▾
Trademark application number 5025502 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5025502? ▾
The trademark agent associated with application number 5025502 is RAHUL CHAUDHRY & PARTNERS.
Was trademark application number 5025502 published in the journal? ▾
Yes, trademark application number 5025502 was published in Journal No. 2009.
What is trademark application number 5025502? ▾
Trademark application number 5025502 relates to "Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified